helptariff
简体中文
中国 → 美国HS 300490其他麻醉剂建议委托报关行

药品 › 由混合或非混合产品构成的治病或防病用药品，已配定剂量或制成零售包装

其他麻醉剂

HS 300490中国 → 美国

目的国关税
0%
普通
联邦增值税（VAT/GST）
无
通关难度
建议委托报关行

1概览

  • 目的国关税: Free (普通, 2 个税号相同) — 与中国无优惠协定，适用基本／最惠国税率。
  • 联邦增值税（VAT/GST）: 无 — 美国没有联邦增值税；各州销售税不在进口环节征收。
  • 该编码涵盖: 其他麻醉剂
  • 额外关税: 至少 +0% — 未找到适用于该原产地与 HS 编码的第99章措施，但这并不保证确实没有。仅适用于该 HS 码的一部分
  • 需留意的制度: 美国小额免税（de minimis）全面中止自 2025-08-29 起，依行政命令 14324，所有国家出口的 800 美元以下货物免税通关已中止。国际邮包与快递小包也须课税，并需办理报关、申报 HS 归类与原产地，小批量寄送难度提高。federalregister.gov

要点

  • 小额免税已无限期暂停：邮递以外方式自 2026-06-24 起，国际邮递自 2026-07-24 起。800 美元免税通关已不存在。
  • 没有联邦增值税；各州销售税或使用税属于进口之后的另一件事，海关不代征。
  • 2,500 美元是简易报关与正式报关的分界。价值 2,500 美元及以下且属 HTSUS 第 1 至 97 章的邮递货物，可适用新设的邮递简易报关程序，关税应于货物抵达次月 7 日前缴纳。
  • 进口商（importer of record）可自行在 ACE 申报，但正式报关须有海关保证金（customs bond），海运货物还须在装船前 24 小时完成进口商安全申报（ISF 10+2）。
  • 第 122 条附加关税已于 2026-07-24 终止，同日起改由覆盖 60 个经济体的第 301 条强迫劳动措施生效。额外关税以第 99 章项目征收，请按报关日核实。

出口方要点

  • 出口前须完成海关进出口货物收发货人备案；对外贸易经营者备案登记已于 2022 年 12 月 30 日起取消。
  • 多数商品不征出口关税，仅《进出口税则》列明的少数商品适用出口关税或出口暂定税率。
  • 出口货物增值税适用零税率或免税，具备资格的企业可按商品编码对应的退税率申报出口退（免）税。
  • 查询商品编码的「监管条件」，确认是否需要出口许可证、两用物项许可（国务院令第 792 号）或法定检验。两用物项许可证管理目录由商务部与海关总署逐年公布。
  • 原产地证书由海关或中国国际贸易促进委员会签发，用于买方在进口国主张优惠税率。
  • 法定检验以《必须实施检验的进出口商品目录》（法检目录）为准，在商品编码的海关监管条件中以 A（进口检验）／B（出口检验）表示，由海关总署以公告动态调整（最近一次：海关总署公告 2026 年第 97 号，2026-07-16 起施行）。申报前请查询该编码的监管条件。

数据日期: 2026 HTS Rev.15 · 说明基准日: 2026-09

2归类

HS6 品名

  • ko기타
  • enOther anesthetics
  • zh_hant其他麻醉劑
  • zh_hans其他麻醉剂

美国 税则子目

子目品名
3004.90.10.00Containing antigens or hyaluronic acid or its sodium saltMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other
3004.90.92OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other
3004.90.92.01For veterinary useMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other
3004.90.92.03Containing acyclovir or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.04Containing oseltamivir or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.05Containing valganciclovir, peramivir or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.06OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.07Containing fluconazole or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antifungals
3004.90.92.08OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antifungals
3004.90.92.09Containing metronidazole or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antiprotozoals (excluding goods described in subheading note 2 to this ch…
3004.90.92.10OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antiprotozoals (excluding goods described in subheading note 2 to this ch…
3004.90.92.11Containing trimethoprim and sulfamethoxazole or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Sulfonamides
3004.90.92.12OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Sulfonamides
3004.90.92.13Containing levofloxacin or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Other
3004.90.92.14Containing linezolid or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Other
3004.90.92.15OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Other
3004.90.92.16Containing hydroxyurea or cyclophosphamide or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Antineoplastic and immunosuppressive medicaments
3004.90.92.17Containing tacrolimus or mycophenolate mofetil or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Antineoplastic and immunosuppressive medicaments
3004.90.92.18OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Antineoplastic and immunosuppressive medicaments
3004.90.92.19Containing metoprolol or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.20Containing amiodarone or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.21Containing diltiazem or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.22Containing hydralazine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.23Containing enoxaparin or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.24Containing labetalol or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.25Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.26OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.27TolmetinMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.28Tolmetin sodium dihydrateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.29Tolmetin sodium (anhydrous)Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.30For oral suspensionMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.31OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.32For oral suspensionMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.33OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.34Containing O-Acetylsalicylic acid (Aspirin)Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.35Containing tramadolMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.36OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.37Containing dexmedetomidine, etomidate, midazolam, propofol or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.38Containing midazolam or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.39Containing phenytoin or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.40Containing propofol or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.41Containing levetiracetam, phenytoin or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.42Containing etomidate or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.43OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.44Containing lorazepam or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Antidepressants, tranquilizers, and other…
3004.90.92.45Containing olanzapine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Antidepressants, tranquilizers, and other…
3004.90.92.46OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Antidepressants, tranquilizers, and other…
3004.90.92.47Containing rocuronium or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Other
3004.90.92.48Containing succinylcholine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Other
3004.90.92.49OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Other
3004.90.92.50Containing lidocaine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Dermatological agents and local anesthetics
3004.90.92.51OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Dermatological agents and local anesthetics
3004.90.92.52LaxativesMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.53AntacidsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.54Containing famotidine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.55Containing pantoprazole or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.56Containing ondansetron or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.57Containing glycopyrrolate or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.58Containing loperamide or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.60OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.61Containing furosemide and its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Diuretics
3004.90.92.62Containing hydrochlorothiazide or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Diuretics
3004.90.92.63OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Diuretics
3004.90.92.64Containing calcium gluconateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.65Containing potassium chlorideMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.66Containing sodium bicarbonate, in injection formMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.67OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.68Cough and cold preparationsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system
3004.90.92.69Containing diphenhydramine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Antihistamines
3004.90.92.70OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Antihistamines
3004.90.92.71Containing albuterol sulfateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other
3004.90.92.72Containing timolol maleateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Other
3004.90.92.73OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Other
3004.90.92.74Containing heparin sodium or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Other
3004.90.92.75Containing zoledronic acid or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Other
3004.90.92.76OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Other
中国 出口侧编码（参考）
  • 30049010---含有磺胺类
  • 30049020---含有联苯双酯
  • 30049051----中药酒
  • 30049052----片仔癀
  • 30049053----白药
  • 30049054----清凉油
  • 30049055----安宫牛黄丸
  • 30049059----其他
  • 30049090---其他

美国 案例前三条

不是你的商品？重新搜索

数据日期: 2026 HTS Rev.15

3关税与税费

与中国无优惠协定，适用基本／最惠国税率。

子目品名普通优惠（special）Column 2
3004.90.10.00Containing antigens or hyaluronic acid or its sodium saltFree—Free
3004.90.92OtherFree—30%
3004.90.92.01For veterinary use———
3004.90.92.03Containing acyclovir or its salts———
3004.90.92.04Containing oseltamivir or its salts———
3004.90.92.05Containing valganciclovir, peramivir or their salts———
3004.90.92.06Other———
3004.90.92.07Containing fluconazole or its salts———
3004.90.92.08Other———
3004.90.92.09Containing metronidazole or its salts———
3004.90.92.10Other———
3004.90.92.11Containing trimethoprim and sulfamethoxazole or their salts———
3004.90.92.12Other———
3004.90.92.13Containing levofloxacin or its salts———
3004.90.92.14Containing linezolid or its salts———
3004.90.92.15Other———
3004.90.92.16Containing hydroxyurea or cyclophosphamide or their salts———
3004.90.92.17Containing tacrolimus or mycophenolate mofetil or its salts———
3004.90.92.18Other———
3004.90.92.19Containing metoprolol or its salts———
3004.90.92.20Containing amiodarone or its salts———
3004.90.92.21Containing diltiazem or its salts———
3004.90.92.22Containing hydralazine or its salts———
3004.90.92.23Containing enoxaparin or its salts———
3004.90.92.24Containing labetalol or its salts———
3004.90.92.25Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts———
3004.90.92.26Other———
3004.90.92.27Tolmetin———
3004.90.92.28Tolmetin sodium dihydrate———
3004.90.92.29Tolmetin sodium (anhydrous)———
3004.90.92.30For oral suspension———
3004.90.92.31Other———
3004.90.92.32For oral suspension———
3004.90.92.33Other———
3004.90.92.34Containing O-Acetylsalicylic acid (Aspirin)———
3004.90.92.35Containing tramadol———
3004.90.92.36Other———
3004.90.92.37Containing dexmedetomidine, etomidate, midazolam, propofol or their salts———
3004.90.92.38Containing midazolam or its salts———
3004.90.92.39Containing phenytoin or its salts———
3004.90.92.40Containing propofol or its salts———
3004.90.92.41Containing levetiracetam, phenytoin or their salts———
3004.90.92.42Containing etomidate or its salts———
3004.90.92.43Other———
3004.90.92.44Containing lorazepam or its salts———
3004.90.92.45Containing olanzapine or its salts———
3004.90.92.46Other———
3004.90.92.47Containing rocuronium or its salts———
3004.90.92.48Containing succinylcholine or its salts———
3004.90.92.49Other———
3004.90.92.50Containing lidocaine or its salts———
3004.90.92.51Other———
3004.90.92.52Laxatives———
3004.90.92.53Antacids———
3004.90.92.54Containing famotidine or its salts———
3004.90.92.55Containing pantoprazole or its salts———
3004.90.92.56Containing ondansetron or its salts———
3004.90.92.57Containing glycopyrrolate or its salts———
3004.90.92.58Containing loperamide or its salts———
3004.90.92.60Other———
3004.90.92.61Containing furosemide and its salts———
3004.90.92.62Containing hydrochlorothiazide or its salts———
3004.90.92.63Other———
3004.90.92.64Containing calcium gluconate———
3004.90.92.65Containing potassium chloride———
3004.90.92.66Containing sodium bicarbonate, in injection form———
3004.90.92.67Other———
3004.90.92.68Cough and cold preparations———
3004.90.92.69Containing diphenhydramine or its salts———
3004.90.92.70Other———
3004.90.92.71Containing albuterol sulfate———
3004.90.92.72Containing timolol maleate———
3004.90.92.73Other———
3004.90.92.74Containing heparin sodium or its salts———
3004.90.92.75Containing zoledronic acid or its salts———
3004.90.92.76Other———

第99章额外关税

至少 +0%

输美时加征于上列 HTS 税率之上的各层措施。每一层均标示状态、基准日与出处。

措施加征第9903号税则状态 · 基准日 · 出处
第232条药品该码项下仅部分 8 位号列在范围内（3004.90.10, 3004.90.92），是否征收取决于实际报关号列。部分下属号列 75 项中的 75 项：3004.90.10, 3004.90.92—未计入合计9903.04.60, 9903.04.61, 9903.04.62, 9903.04.63, 9903.04.64, 9903.04.65, 9903.04.66, 9903.04.67, 9903.04.68, 9903.04.69施行中数据日期: 2026-09-15Proclamation 11020, 2 April 2026, 91 FR (2026-06956); CBP CSMS #69395344 (2026-07-30) and #69415934 (2026-08-01)
IEEPA对等关税（已失效）现已不再征收（2026-09-09 基准）。因该日期之前的资料仍在引用，故一并列出。—未计入合计9903.01, 9903.02被判无效相关诉讼进行中数据日期: 2026-09-09Learning Resources, Inc. v. Trump, No. 24-1287 (U.S. 20 Feb 2026)
IEEPA芬太尼关税（中国，已失效）现已不再征收（2026-02-20 基准）。因该日期之前的资料仍在引用，故一并列出。—未计入合计9903.01被判无效相关诉讼进行中数据日期: 2026-02-20CRS LSB11398, Supreme Court rules against IEEPA tariffs
第122条国际收支附加税（已届期）现已不再征收（2026-07-24 基准）。因该日期之前的资料仍在引用，故一并列出。—未计入合计—已失效相关诉讼进行中数据日期: 2026-07-24Section 122 surcharge: imposed 24 Feb 2026, CIT ruling 7 May 2026, expired 24 July 2026
加征合计至少 +0%

注意事项

  • 合计为下限而非完整估算：第232条药品 无法仅凭 HS 编码量化。
  • 该 HS 码部分在范围内、部分不在（3004.90.10, 3004.90.92），以实际报关的 8 位号列为准。
  • 这些措施以 8 位或 10 位 HTS 税则号列界定。HS6（300490）只能呈现大致情形。
  • US$800 小额免税已暂停，低价包裹同样课税；法律上的废止于 2027-07-01 生效。
  • 关税不是全部：另有 MPF 与（海运时）HMF，本页并未计入。
  • 2026-09-15 基准的信息提供。以报关日施行中的 HTSUS 第99章注释与 CBP CSMS 指引为准 — 请向 CBP 或报关行确认。
小额免税（de minimis）状态

美国 800 美元小额免税

自 2025-08-29 起对所有国家停止适用，并经 2026-06-24 CBP 临时最终规则无限期停止（非邮递立即生效，国际邮件自 2026-07-24）。2026-08-13 国际贸易法院驳回对该停止的诉讼，制度更趋确定。2027-07-01 起依 One Big Beautiful Bill Act 废止；截至 2026-09-09 复查，尚无变更该日期的立法。100 美元礼品与 200 美元随身物品免税仍存续。附有第99章关税的货物不得使用邮递简易报关。

门槛金额:
US$800
暂停适用:
2025-08-29
法律废止:
2027-07-01
CBP interim final rules, 91 FR (2026-12670 / 2026-12669), 24 June 2026

仅供参考，非专业建议。美国附加关税变动频繁且诉讼进行中。实际税额以报关日生效的 HTSUS 第99章注释与 CBP CSMS 公告为准，请向 CBP 或报关行确认。

数据日期: 2026-09-15

  • · 美国没有联邦层级的增值税，海关只征收关税与规费。
  • · 商品处理费（MPF）：正式报关时为申报价格的 0.3464%，上下限每个财政年度按物价重新调整。2026 财政年度（至 2026-09-30）为 33.58 至 651.50 美元；2027 财政年度（自 2026-10-01 起）为 34.58 至 670.86 美元。简易报关改按定额收取，2027 财政年度为 2.77、8.30 或 12.45 美元。
  • · 港口维护费（HMF）：以船舶运抵的货物按价格 0.125% 计收。
  • · 各州销售税或使用税针对货物的后续销售或使用，由各州税务机关管理，与 CBP 无关。
  • · 第 99 章的额外关税加计于一般税率之上。截至 2026-09，包括第 232 条措施与 2026-07-24 生效的第 301 条强迫劳动措施；第 122 条附加关税已于 2026-07-24 终止。请按报关日确认适用情况。

税费概算

采用税率
0%
完税价格
—
关税
—
额外关税（第99章） (≥ 0%)
—
联邦增值税（VAT/GST）
—
预估合计
—

此为概算。实际金额取决于完税价格审定、归类与原产地认定。

数据日期: 2026 HTS Rev.15

4监管要求

  • FD2FDA

    Pharmaceutical products (medicaments, blood, dressings) - FDA-regulated drug/biologic (FD2). Potential/disclaimable flag; submit FDA entry data if FDA-regulated.

    可信度:
    chapter-heuristic
    fda.gov
  • headingDEA

    Medicaments (subset containing controlled substances) - DEA import registration/permit for scheduled-drug content. Substance-dependent, narrow.

    可信度:
    chapter-heuristic
    dea.gov

CBP 未完整公开各 HS 的 PGA 标记，此处以章／品目层级启发式映射。

相关机关

  • 美国海关与边境保护局（CBP）办理进口通关、核定关税与规费，并在口岸执行其他机构的规定cbp.gov
  • 美国国际贸易委员会（USITC）编制并公布 HTSUS，含第 99 章额外关税条款hts.usitc.gov
  • 美国食品药品监督管理局（FDA）食品、药品、医疗器械与化妆品；事先通报与 MoCRA 注册列名fda.gov
  • 美国农业部动植物卫生检验局（APHIS）动植物产品的进口许可与检疫要求aphis.usda.gov
  • 美国联邦通信委员会（FCC）无线电频率设备与设备认证fcc.gov
  • 美国消费品安全委员会（CPSC）消费品与儿童用品认证cpsc.gov

数据日期: 2026-08-27

5单证

中国 出口单证

  • 出口货物报关单
    签发:
    发货人或受委托的报关企业，通过中国国际贸易单一窗口申报
    时点:
    货物装运前

    跨境电商出口使用 9610、9710、9810 等专门监管方式代码。

    官方页面
  • 商业发票与装箱单
    签发:
    出口企业
    时点:
    报关时

    载明品名、规格、数量、单价、贸易条件与原产地，也是进口国海关审价的依据。

    官方页面
  • 提单（B/L）或空运单（AWB）
    签发:
    承运人或货运代理
    时点:
    装运后签发

    用于结汇与买方提货，也是办理出口退税的凭证之一。

    官方页面
  • 出口许可证 / 两用物项和技术出口许可证
    签发:
    商务部及其授权发证机构
    时点:
    属管制或许可证管理商品的，报关前取得

    两用物项须核查最终用户与最终用途；部分物项另有专门的管制清单。

    官方页面
  • 出境货物检验检疫单证
    签发:
    海关
    时点:
    属法定检验目录商品的，报关前完成

    包括抽样检验、检疫处理与相应证书。

    官方页面
  • 原产地证书
    签发:
    海关或中国国际贸易促进委员会（CCPIT）
    时点:
    买方在进口国主张优惠税率时

    包括 RCEP、中韩自贸协定原产地证书、输往台湾地区的 ECFA 原产地证明书，以及一般原产地证书（CO）。

    官方页面
  • 报关委托协议
    签发:
    出口企业与报关企业
    时点:
    委托代理报关前

    明确双方的申报责任与授权范围。

    官方页面
  • 出口退（免）税申报资料
    签发:
    出口企业
    时点:
    货物报关出口并收汇后

    包括增值税专用发票或进货凭证、出口货物报关单信息与收汇凭证。

    官方页面
  • 订舱单 / 装货单
    签发:
    承运人或货运代理
    时点:
    订舱后取得

    作为货物进入海关监管作业场所与装运的依据。

    官方页面

美国 进口单证

  • CBP Form 3461（Entry/Immediate Delivery，放行申报表）
    签发:
    美国海关与边境保护局（CBP）
    时点:
    抵达时或抵达前，通过 ACE 电子传输

    放行用文件，一般可在抵达前 5 日内递交。

    官方页面
  • CBP Form 7501（Entry Summary，报关摘要表）
    签发:
    美国海关与边境保护局（CBP）
    时点:
    放行后 10 个工作日内

    载明 HTSUS 归类、完税价格与税额计算，可逐票缴纳或以按月汇总结算方式缴纳。

    官方页面
  • 商业发票
    签发:
    卖方或出口商
    时点:
    随报关单证

    应载明买卖双方、品名、数量、单价与总价、币种、贸易条件与原产地。

    官方页面
  • 装箱单
    签发:
    卖方或出口商
    时点:
    随报关单证

    逐箱内容、重量与唛头，查验时使用。

    官方页面
  • 提单（B/L）或空运单（AWB）
    签发:
    承运人或货运代理
    时点:
    装运时签发

    运输合同与提货权利的凭证。

    官方页面
  • 进口商安全申报（ISF 10+2）
    签发:
    进口商或其代理人
    时点:
    货物装船前至少 24 小时

    仅适用于海运货物，空运、公路与铁路运输不适用。

    官方页面
  • 海关保证金（单票或连续型）
    签发:
    美国财政部认可的担保机构
    时点:
    报关前设立

    正式报关与新设的邮递简易报关程序均须具备。

    官方页面
  • 自由贸易协定原产地声明
    签发:
    出口商、生产商或进口商
    时点:
    主张优惠税率时持有

    韩国原产货物适用美韩 FTA，采自我证明、无固定格式，报关时以特别方案代码 KR 主张。台湾地区与中国大陆同美国之间没有自由贸易协定。

    官方页面
  • 其他主管机构资料（PGA data）
    签发:
    FDA、USDA、FCC、CPSC、EPA 等
    时点:
    随报关单证

    例如食品的 FDA 事先通报（Prior Notice）、依 MoCRA 办理的化妆品工厂注册与产品列名并指定美国责任人、无线电设备的 FCC 符合性声明、儿童用品的 CPSC 证书。

    官方页面

6流程

  1. 装船前申报进口商或代理人在货物装船前至少 24 小时完成进口商安全申报（ISF 10+2），承运人也按同一 24 小时期限传输预报舱单。
  2. 递交报关单证通过 ACE 递交 CBP Form 3461，一般可在抵达前 5 日内申报。抵达后 15 个日历日内未申报的，货物将转入 General Order 仓库。
  3. 审核、查验与机构扣留CBP 可能指定单证审核、X 光或人工查验，FDA、USDA、CPSC 等主管机构也可能另行扣留。
  4. 放行CBP 与各机构的扣留解除后，货物即可放行离开港区。
  5. 报关摘要与缴税放行后 10 个工作日内递交 CBP Form 7501，并缴纳关税、商品处理费与港口维护费，可逐票或按月汇总结算缴纳。
  6. 税额确定（Liquidation）CBP 通常在报关后 314 日内确定税额。事后更正（post-summary correction）与异议（protest）另有期限。
  1. 预报舱单航空公司在抵达前传输预报货物信息。进口商安全申报（ISF）不适用于空运货物。
  2. 递交报关单证通过 ACE 递交 CBP Form 3461，多在航班落地前申报，以便抵达后尽快放行。
  3. 审核与机构扣留CBP 与其他主管机构审核申报，并可能在机场货运站查验。
  4. 放行提货放行后即可从航空货运站提取货物。
  5. 报关摘要与税额确定放行后 10 个工作日内处理 CBP Form 7501 与税款，之后比照海运货物办理税额确定。
  1. 预先传输数据快递企业或邮政机构在货物抵达前将数据传送 CBP。
  2. 报关自 2026-06-24 起，低价值货物不得再凭舱单放行。快件以简易报关（通常为 Entry Type 11）办理，超过 2,500 美元的必须办理正式报关。
  3. 邮递货物自 2026-07-24 起，价值 2,500 美元及以下且可归入 HTSUS 第 1 至 97 章的邮递货物，可适用邮递简易报关程序，由持照报关行或货物所有人、购买人申报，并须具备基本的进口与报关保证金。
  4. 税费计算与缴纳按申报价格计算关税与规费。快递企业通常先行垫付关税再向买方收取；邮递程序下，关税最迟应在包裹抵达次月 7 日前缴纳。
  5. 机构审查与派送食品、化妆品、药品、无线电设备与儿童用品仍须附送主管机构资料。涉及配额、反倾销或反补贴税、第 98 章或第 99 章关税，或主张自由贸易协定优惠的，不得使用邮递简易报关程序。
  1. 入境申报旅客以 CBP Form 6059B 或电子申报方式申报在境外取得的全部物品，并回答入境口岸 CBP 人员的询问。
  2. 个人免税额返美的美国居民一般享有 800 美元个人免税额；非居民随身携带、价值 200 美元及以下的个人与家用物品，依 19 U.S.C. 1321(a)(2)(B) 仍免税。
  3. 商业性货物为转售而携带的货物不适用个人免税额，须与一般进口同样办理简易或正式报关，其他主管机构的规定同样适用。
  4. 缴税超出免税额而申报的物品，其关税在旅客离开海关监管区前于入境口岸缴纳。
显示 中国 出口侧流程
  1. 资质与前置查询完成海关进出口货物收发货人备案与出口退税相关备案；查询商品编码对应的监管条件与出口退税率，判断是否需要许可证或法定检验。
  2. 订舱、备货与办证订舱并取得装货单，完成包装与唛头；办理出口许可证、两用物项许可与出境检验检疫。
  3. 申报出口货物报关单在货物运抵海关监管区后、装货的 24 小时以前，经单一窗口提交（海关总署令第 277 号第 7 条）。可自行申报，也可委托报关企业办理。
  4. 查验与检验检疫配合海关查验，属法定检验商品的完成检验检疫程序。
  5. 放行与装船离境海关放行后装船离境，取得提单与报关单结关信息。
  6. 收汇与退税办理收汇，并按规定申报出口退（免）税；单证与信息须相互匹配。

7难度

建议委托报关行

分数: 0.92

这是依公开数据计算的信号，并非咨询意见。

判定理由

  • regime[FDA] FDA drug (+ DEA if controlled)制剂药品；若含管制物质成分，还须办理 DEA 进口登记／许可。fda.gov2026-09-07
  • requirement目的国进口要求 2 件：Medicaments (subset containing controlled substances) - DEA import registration/permit for scheduled-drug content. Substance-dependent, narrow., Pharmaceutical products (medicaments, blood, dressings) - FDA-regulated drug/biologic (FD2). Potential/disclaimable flag; submit FDA entry data if FDA-regulated.dea.gov2026-09-07
  • ambiguity品目归类易生争议 — US 案例 1057 件分散于 103 个下位税号。rulings.cbp.gov2026-09-07
  • timing自 2025-08-29 起，依行政命令 14324，所有国家出口的 800 美元以下货物免税通关已中止。国际邮包与快递小包也须课税，并需办理报关、申报 HS 归类与原产地，小批量寄送难度提高。federalregister.gov2026-09-07

组成

进口要求0.76Medicaments (subset containing controlled substances) - DEA import registration/permit for scheduled-drug content. Substance-dependent, narrow. dea.govPharmaceutical products (medicaments, blood, dressings) - FDA-regulated drug/biologic (FD2). Potential/disclaimable flag; submit FDA entry data if FDA-regulated. fda.govCBP 未提供完整的逐项 HS PGA 标记文件，故采用章／节启发式对应（confidence=chapter-heuristic）。 customs_v0.sqlite:us_requirements
归类模糊度0.80US 归类决定案例 1057 件 · 分散于 103 个下位税号 rulings.cbp.gov美国 CROSS 1057 件中，涉及多个税号者占 21% · 同案一并审视的其他 HS6 共 66 个 rulings.cbp.gov
管制制度1.00FDA drug (+ DEA if controlled) fda.gov
中国 出口侧备注: 未持有中国逐项 HS 出口规定表；商检（CIQ）与出口许可须另行确认。

数据日期: 2026-09-07

8案例

持有案例:韩国 197 件美国 1057 件台湾 17 件中国 —

先列出目的国核定机关的案例，并按日期由新到旧排序。相似案例本身并不等于同一归类。

美国 案例（目的国）

共 1057 件，显示最新 10 件

再显示 5 件

中国 案例（出发国）

中国 没有公开的商品归类案例库，因此没有可显示的案例。

显示其他国家的案例（20 件）
  • KR관세평가분류원ㅇ 재우스오라쿠고에이취플라스타(살리실산); OLAKUKO - H;ㅇ 물품개요 - 살리실산을 주성분으로 한 황색 페이스트를 원형 스펀지 중앙에 채운 후 스트립상의 접착시트에 부착한 것을 소매포장한 것(내용량 : 100g, 12매/box) - 용도: 티눈, 굳은 살, 사마귀 제거(일반의약품)核定编码: 3004909900日期: 2026-02-12文号: CLIP-0072026000156
  • KR관세평가분류원Medicaments; 재우스오라쿠고에이취플라스타(살리실산)- 살리실산을 주성분으로 한 황색 페이스트를 원형 스펀지 중앙에 채운 후 스트립상의 접착시트에 부착한 것을 지제상자에 소매포장한 것(내용량 : 100g, 12매/box) - 용도 : 일반의약품(티눈, 굳은 살, 사마귀 제거) ※ 품목분류는 수출입신고 당시의 물품 상태에 따라 변경될 수 있음核定编码: 3004909900日期: 2025-11-11文号: CLIP-0072025004895
  • KR관세평가분류원POSSㅇ 물품개요 - ① 돼지의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 분말상을 유리용기에 충전한 후 플라스틱제 용기에 블리스터 소포장하여 사용설명서와 함께 종이상자에 소매포장한 것(내용량 : 0.25g) ② 소의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 그래뉼상...核定编码: 3004909900日期: 2024-03-11文号: CLIP-0072023004368
  • KR관세평가분류원S1ㅇ 물품개요 - ① 돼지의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 분말상을 유리용기에 충전한 후 플라스틱제 용기에 블리스터 소포장하여 사용설명서와 함께 종이상자에 소매포장한 것(내용량 : 0.25g) ② 소의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 그래뉼상...核定编码: 3004909900日期: 2024-03-11文号: CLIP-0072023004366
  • KR관세평가분류원BOSSㅇ 물품개요 - ① 돼지의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 분말상을 유리용기에 충전한 후 플라스틱제 용기에 블리스터 소포장하여 사용설명서와 함께 종이상자에 소매포장한 것(내용량 : 0.25g) ② 소의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 그래뉼상...核定编码: 3004909900日期: 2024-03-11文号: CLIP-0072023004367
  • KR관세평가분류원Medicaments; DIABEX XR 500mg메트포르민염산염, 미결정셀룰로오스, 스테아르산 마그네슘, 카르복시메틸셀룰로오스나트륨, 히프로멜로오스, 정제수를 혼합하여 조제한 백색 타원형 정제를 수지제 블라스터 포장한 것을 종이제 상자에 소매포장한 것(내용량: 15 x 4ea/60정) - 용도: 경구용 혈당 강하제 ※ 품목분류는 수출입신고 당시의 물품상태에...核定编码: 3004909900日期: 2023-07-14文号: CLIP-0072023002558
  • KR관세평가분류원INVISIBLE MASKㅇ 물품개요 - Hydroxypropyl methylcellulose 95%에 레몬향 분말을 혼합·조제한 백색계 분말을 플라스틱 용기에 충전 후 종이상자에 소매포장한 것(내용량 : 800㎎) - 작용 : 비강 내부에 분사하면 내용물이 비강 내의 습기와 결합하여 겔(gel)형태로 변하여 내부를 피복함 - 기능 ...核定编码: 3004909900日期: 2023-03-27文号: CLIP-0072023001085
  • KR관세평가분류원Medicaments, packings for retail sale①건조 쑥분말 86%에 물 11%, 칼슘(쑥봉 타는 속도 지연), 옥수수전분(점결제)을 혼합하여 원통형으로 압축 성형 후 건조한 쑥봉에 종이재질의 원통형 지지물(지관)을 결합하고 하단에 접착스티커를 부착시킨 것 180개, ②이면지에 부착된 원형의 피부보호용 스티커(무흔지) 2장, ③제품사용설명서(주요 뜸자리)...核定编码: 3004909900日期: 2021-04-12文号: CLIP-0072021001331
  • KR관세평가분류원Medicament; Mentho Pas Lotionㅇ 살리실산메틸, L-멘톨, 리놀린유, 미네랄오일, 소르비탄스테아레이트, 정제수, 카보머941, 트롤아민, 폴리소르베이트60으로 혼합·조제된 백색계 점조액상을 플라스틱 용기에 포장 후 지제박스에 최종 소매포장(내용량 : 100ml)한 것 - 용도 : 의약품(근육통, 요통, 류마티스통증 등 환부에 바름) ※ ...核定编码: 3004909900日期: 2021-04-06文号: CLIP-0072021001328
  • TW其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者恢甲清覆甲液-全日型加強配方(未滅菌) EXCILOR FORTE-nail solution(non-sterile)核定编码: 30049099904日期: 2021文号: 110AA0179
  • KR관세평가분류원Medicaments, anti-cancer preparation TEPADINA, Thiotepaㅇ 주입용액 조제용 티오테파(Thiotepa) 백색 분말을 유리제 용기에 넣어 지제박스에 소매포장한 것(내용량: 15㎎) - 용도 : 항암제(혈액질환, 고형종양 등) ※ 품목분류는 수출입신고 당시의 물품상태에 따라 변경될 수 있음核定编码: 3004901000日期: 2020-04-02文号: CLIP-0072020001282
  • KR관세평가분류원Medicaments; 인애백년보건고; PR.CHNAㅇ쑥, 생강, 삼칠초, 홍화, 혈갈, 용뇌향을 섞어 열처리 후 농축정제한 물품에 밀랍 68%를 혼합하여 고체상태로 만들어 소매포장(1,000g/통)한 것 - 용도 : 찜질용(목, 어깨, 허리, 무릎 등 피로로 인하여 불편한 부위 완화)核定编码: 3004909900日期: 2019-08-16文号: CLIP-0072019003378
  • KR관세평가분류원Medicaments; FD; MEXICOLidocaine hydrochloride(2 %), Epinephrine(0.001 %), Sodium chloride, Water 등으로 조성된 무색 투명 액상의 주사액을 플라스틱제 앰플에 소매포장한 것(1.8 ml x 10 cartridges) - 용도: 치과용 국소마취제核定编码: 3004909900日期: 2018-11-19文号: CLIP-0072018005196
  • KR관세평가분류원Medicaments; Turbocaina; MEXICOㅇArticaine hydrochloride(4%), Epinephrine(0.001%), Sodium chloride, Water 등으로 조성된 국부마취제 성분의 주사액를 주입한 유리제 앰플을 소매포장한 것(1.8mL×50cartridges) ㅇ용도 : 치과용 국소마취제核定编码: 3004909900日期: 2018-08-23文号: CLIP-0072018003090
  • KR관세평가분류원Medicaments; Nutriband Slimline patch; U.S.Aㅇ 클로로겐산, L-타우린, 라즈베리케톤, 녹차추출물 등으로 도포하고 이형지를 부착한 직사각형의 패치(25 X 75mm)를 알루미늄 증착 팩에 개별 포장한 것 - 용도 : 피부에 부착하여 식욕억제 및 다이어트 효과를 줌核定编码: 3004909900日期: 2018-06-21文号: CLIP-0072018002940
  • KR관세평가분류원Collagen Preparation; COLTRIX CartiRegen돼지 추출 콜라겐, 이염기인산나트륨, 염화나트륨, 콜라겐용해액 등으로 조제된 물품이 플라스틱 주사기에 삽입 밀봉되었고, 주입 할 수 있는 주사바늘이 세트 포장되어 살균 및 밀봉된 소매용 완제품임(내용량 3% collagen 1cc 주사기 x 2EA/set) - 용도 : 연골, 뼈 보충에 사용 ※ 품목분류는 수...核定编码: 3004909900日期: 2018-05-16文号: CLIP-0072018002319
  • TW其他中藥製劑枳椇人參茶(Gan-Pyun-Han-Nal) / 液體茶 / 100ML /瓶核定编码: 30049069009日期: 2018文号: 107AA0256
  • TW其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Hiruscar Silicone Pro(non-sterile) 喜療疤 疤痕護理矽凝膠(未滅菌)核定编码: 30049099904日期: 2018文号: 107AA0177
  • TW其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者貽貝粘蛋白創面修復敷料 型號、規格：0.5mg/mL×0.2mL、0.5mg/mL×0.5mL、0.5mg/mL×1mL、0.5mg/mL×3mL、0.5mg/mL×5mL 0.5mg/mL×10mL、0.5mg/mL×15mL、0.5mg/mL×20mL、1.5mg/mL×0.2mL、1.5mg/mL×0.5mL 1.5mg/mL×3mL、……、1.5mg/mL×20mL等(詳附件)核定编码: 30049099904日期: 2018文号: 107AA0128
  • TW其他中藥製劑云南彝葯排毒眼罩核定编码: 30049069009日期: 2018文号: 107AA0382

来源: Federal Register: Indefinite Suspension of the De Minimis Exemption for Merchandise Arriving Through All Modes Other Than the International Postal Network · Federal Register: Indefinite Suspension of the De Minimis Exemption for Mail Shipments and New Postal Informal Entry Process · Federal Register: Notice of Implementation of Executive Order 14324, Suspending Duty-Free De Minimis Treatment for All Countries · CBP Form 7501, Entry Summary (revision 02/26) · CBP: Importer Security Filing (10+2) · Harmonized Tariff Schedule of the United States · Supreme Court of the United States: Learning Resources, Inc. v. Trump (No. 24-1287) · FDA: Registration and Listing of Cosmetic Product Facilities and Products · 联邦公报 — 第 11012 号公告：征收临时进口附加关税（第 122 条，2026-07-24 终止） · 联邦公报 — 第 301 条强迫劳动调查措施（60 个经济体，2026-07-24 生效） · 联邦公报 — 2027 财政年度海关使用者规费物价调整（CBP） · eCFR — 19 CFR 141.5：申报期限（抵达后 15 个日历日） · 中国国际贸易单一窗口 · 海关总署网上办事服务 — 办事指南（企业备案与申报） · 海关总署 · 商务部 · 国家税务总局 — 出口退（免）税 · 中国国际贸易促进委员会 · 中国政府网 — 中华人民共和国两用物项出口管制条例（国务院令第 792 号，2024-12-01 施行） · 中国商务部 — 2026 年度《两用物项和技术进出口许可证管理目录》（商务部、海关总署 2025 年第 91 号公告） · 中国国务院公报 — 中华人民共和国海关进出口货物申报管理规定（海关总署令第 277 号，2025-05-01 施行） · 中国财政部关税司 — 中华人民共和国关税法（2024-12-01 施行） · 中国司法部 — 进出口商品检验法实施条例（国务院令第 447 号，2013 年修订）第 3 条法检目录

身份: 报关行 — 会改变页面强调的板块